View Document Preview and Link Document Date: 2012-09-24 16:48:42 Open Document File Size: 212,41 KB Share Result on Facebook
City Montreal / Ottawa / Vancouver / Toronto / Laval / Saskatoon / Halifax / Kingston / Sainte-Foy / Calgary / / Company Pulsus Group Inc. / GlaxoSmithKline Inc / Boehringer Ingelheim (Canada) Inc / Bristol-Myers Squibb / ALTANA Pharma Inc / Pfizer / Bayer Canada Inc / AstraZeneca Canada Inc / / Country Canada / / / Event Reorganization / / Facility 2Dalhousie University / Clinically stable / Queen’s University / 12McMaster University / stable COPD / The Canadian College of Family Physicians / / / IndustryTerm evidence-based treatment algorithms / Arterial blood gas measurements / treatment of exacerbations and complications of the disease / pharmaceutical / prompt management / / MedicalCondition common respiratory illness / reserved 1A O’Donnell et al DEFINITION AND PATHOPHYSIOLOGY Chronic / dysfunction / ischemic heart disease / chronic dyspnea / pulmonary / stable COPD / muscle cramps / dyspnea scale Grade Description / metabolic disorders / illness / severe disease / acute bronchitis / cessation COPD / asthma / malnutrition / MANAGEMENT COPD / pneumonia / respiratory illness / cancer / Annual influenza / respiratory failure / shortness of breath / pulmonary function / LABA Pulmonary / chronic / diabetes / pulmonary vascular disease / optimal COPD / metabolic syndrome / chronic respiratory failure / diseases / osteoporosis / Sputum production Infrequent Often Allergies Often Infrequent Disease / COPD RECOMMENDATIONS / depression / dyspnea and other respiratory symptoms / dyspnea scale / interstitial lung disease / cor pulmonale / glaucoma / Pseudomonas / obstructive pulmonary disease / COPD / inflammatory process / EPIDEMIOLOGY IN CANADA COPD / muscle weakness / infectious / disability COPD / tremor / mild COPD / severe COPD / neuromuscular disease / obesity / persistent inflammation / pulmonary embolism / tachycardia / peripheral muscle dysfunction / influenza / partially reversible airway obstruction / Additional pulmonary function / reduced dyspnea / respiratory disorder / osteopenia / insomnia / congestive heart failure / hypertension / progressive dyspnea / airway obstruction / cataracts / disease / dyspnea / chronic obstructive pulmonary disease / pulmonary hypertension / oral candidiasis / dysphonia / chronic lung disease / cough / inflammation / anemia / cataract / / MedicalTreatment self-management / vaccination / Surgery / OXYGEN THERAPY / lung volume reduction surgery / nicotine replacement therapy / pharmacotherapy / Antibiotics / counselling / Vaccinations / / NaturalFeature Richmond Hill / / Organization 12McMaster University / Department of Medicine / Canadian Thoracic Society COPD Guidelines Development Committee / Division of Respiratory and Critical Care Medicine / MRC Medical Research Council / 5McGill University / Montreal / Medical Research Council / Canadian Thoracic Society / Canadian College / Queen’s University / 2Dalhousie University / / Person Gordon Ford / Jean Bourbeau / Alan Kaplan / Francois Maltais / Paul Hernandez / Shawn Aaron / Yves Lacasse / Darcy Marciniuk / Don Sin / Andre Gervais / / / Position family physician / physician / ‡Chair / speaker / †Chair / / Product trimethoprim / Symbicort / Theophylline / Amoxicillin / prednisone / nicotine / ipratropium bromide / doxycycline / Ford MD8 / sulfamethoxazole / / ProvinceOrState Quebec / Saskatchewan / British Columbia / Nova Scotia / Ontario / Alberta / / PublishedMedium the Canadian Respiratory Journal / Critical Care Medicine / / Technology evidence-based treatment algorithms / transplantation / / URL www.COPDguidelines.ca / / SocialTag 
COPD RECOMMENDATIONS – 2008 PRIMARY CARE UPDATE Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary care